TrialJournal of the American Heart Association2022

Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT.

Senthil Selvaraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.